Merck and Co. Inc. - Revision history

Richard Bew: /* Public Relations, Lobbying and Business Intelligence Firms */

2016-04-29T11:14:11Z

Public Relations, Lobbying and Business Intelligence Firms

Josh Leeson at 16:33, 30 March 2015

2015-03-30T16:33:48Z

Josh Leeson at 17:04, 29 January 2015

2015-01-29T17:04:14Z

Matthew Pringle: Policy Exchange category added

2014-02-27T16:02:44Z

Policy Exchange category added

Matthew Pringle: Policy Exchange funding added

2014-02-27T16:00:35Z

Policy Exchange funding added

Claire Robinson: /* The company */

2009-02-17T21:52:02Z

The company

Marisa de Andrade at 21:41, 17 February 2009

2009-02-17T21:41:30Z

Lindsay Siebelt at 15:20, 22 April 2008

2008-04-22T15:20:46Z

David: /* The company */

2008-04-20T21:07:05Z

The company

Lynn Hill: /* Public Relations, Lobbying and Business Intelligence Firms */

2008-03-20T11:51:32Z

Public Relations, Lobbying and Business Intelligence Firms

@@ Line 63: / Line 63: @@
 ==Public Relations, Lobbying and Business Intelligence Firms==
 *[[Weber Shandwick]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=Weber%20Shandwick Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 29 January 2015 </ref>
 Merck appears as a client with [[Rabin Strategic Partners]]<ref>Rabin Strategic Partners [http://www.rabinpartners.com/ Our Clients] Accessed 2nd January 2008</ref> (A full-service consultany, public relations and communications agency) alongside [[Johnson & Johnson]]. However the nature of the link between the two companies is not divulged.

@@ Line 93: / Line 93: @@
 * [[Let's Face It]]
 * [[Get Ahead]]
 == External links ==

← Older revision		Revision as of 17:04, 29 January 2015
Line 62:		Line 62:

	==Public Relations, Lobbying and Business Intelligence Firms==		==Public Relations, Lobbying and Business Intelligence Firms==
		+	*[[Weber Shandwick]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=Weber%20Shandwick Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 29 January 2015 </ref>
		+
	Merck appears as a client with [[Rabin Strategic Partners]]<ref>Rabin Strategic Partners [http://www.rabinpartners.com/ Our Clients] Accessed 2nd January 2008</ref> (A full-service consultany, public relations and communications agency) alongside [[Johnson & Johnson]]. However the nature of the link between the two companies is not divulged.		Merck appears as a client with [[Rabin Strategic Partners]]<ref>Rabin Strategic Partners [http://www.rabinpartners.com/ Our Clients] Accessed 2nd January 2008</ref> (A full-service consultany, public relations and communications agency) alongside [[Johnson & Johnson]]. However the nature of the link between the two companies is not divulged.

← Older revision		Revision as of 16:02, 27 February 2014
Line 116:		Line 116:
	[[Category:Pharmaceutical Industry]]		[[Category:Pharmaceutical Industry]]
	[[Category:Big Pharma]]		[[Category:Big Pharma]]
		+	[[Category:Policy Exchange]]

← Older revision		Revision as of 16:00, 27 February 2014
Line 75:		Line 75:

	Merck Sharp and Dohme is reported to be a principle funder and Business Forum member for the [[Social Market Foundation]] in 2005/06<ref>Social Market Foundation [http://www.smf.co.uk/assets/files/annual_reports/Annual%20Report%202005%2006.pdf Annual Report 2005/06] Accessed 6th March 2008</ref>		Merck Sharp and Dohme is reported to be a principle funder and Business Forum member for the [[Social Market Foundation]] in 2005/06<ref>Social Market Foundation [http://www.smf.co.uk/assets/files/annual_reports/Annual%20Report%202005%2006.pdf Annual Report 2005/06] Accessed 6th March 2008</ref>
		+
		+	==Policy Exchange funding==
		+	Merck donated £17,500 to [[Policy Exchange]] in May 2009 to support research into drugs pricing.<ref>MERCK, Corporate Social Responsibility, [http://www.merck.com/corporate-responsibility/docs/countries/United-Kingdom-09.pdf Q1/2 2009 Grants & Donations to Institutions and payments to Patient Organizations United Kingdom].</ref>

	==Patient Groups==		==Patient Groups==

@@ Line 3: / Line 3: @@
 == The company ==
-Merck & Co., Inc. should not be confused with [[Merck KGaA]]. While [[Merck KGaA]] is allegedly the World's oldest pharmaceutical and chemical company and based in Germany, the U.S. company Merck & Co. became independent after the First World War. [http://pb.merck.de/servlet/PB/menu/1014710/index.html]
+Merck & Co., Inc. should not be confused with [[Merck KGaA]]. While [[Merck KGaA]] is allegedly the world's oldest pharmaceutical and chemical company and based in Germany, the U.S. company Merck & Co. became independent after the First World War. [http://pb.merck.de/servlet/PB/menu/1014710/index.html]
 Merck & Co is the former U.S. subsidiary of the [[Merck Group]] (under the umbrella of [[Merck KGaA]]) and became independent in 1917.<ref> Merck Pharmaceuticals UK [http://www.merck-pharmaceuticals.co.uk/ Welcome to Merck] Accessed 13th December 2007</ref>

← Older revision		Revision as of 21:41, 17 February 2009
Line 112:		Line 112:

	[[Category:Pharmaceutical Industry]]		[[Category:Pharmaceutical Industry]]
−	[[Category: ~~Pharmaceutical Industry~~]]	+	[[Category:Big Pharma]]

← Older revision		Revision as of 15:20, 22 April 2008
Line 1:		Line 1:
−	'''Merck & Co., Inc.''' describes itself as "a global research-driven pharmaceutical company dedicated to putting patients first." [http://www.merck.com/about/] "Putting patients first" has so far "led to more than 27,000 heart attacks and sudden cardiac deaths" [http://www.msnbc.msn.com/id/6192603/] through their arthritis treatment Vioxx between its approval in 1999 and its withdrawal from the market in 2004.	+	[[Image:Merck-Logo_svg.png\|thumb\|right\|300px\|Merck's logo]]'''Merck & Co., Inc.''' describes itself as "a global research-driven pharmaceutical company dedicated to putting patients first." [http://www.merck.com/about/] "Putting patients first" has so far "led to more than 27,000 heart attacks and sudden cardiac deaths" [http://www.msnbc.msn.com/id/6192603/] through their arthritis treatment Vioxx between its approval in 1999 and its withdrawal from the market in 2004.

	== The company ==		== The company ==

← Older revision		Revision as of 21:07, 20 April 2008
Line 8:		Line 8:

	The UK subsidiary of Merck & Co is called [[Merck Sharp & Dohme Limited]] (MSD) which has two sites in the UK. Its headquarters and pharmaceutical research and development laboratories are located in Hoddesdon, Hertfordshire and its manufacturing is located at Cramlington in Northumberland. <ref>MSD UK [http://www.msd-uk.co.uk/ home page] Accessed 13th December 2007</ref>		The UK subsidiary of Merck & Co is called [[Merck Sharp & Dohme Limited]] (MSD) which has two sites in the UK. Its headquarters and pharmaceutical research and development laboratories are located in Hoddesdon, Hertfordshire and its manufacturing is located at Cramlington in Northumberland. <ref>MSD UK [http://www.msd-uk.co.uk/ home page] Accessed 13th December 2007</ref>
		+
		+	[[Sanofi Pasteur MSD]] is a 50/50 joint venture between Merck and [[Sanofi Aventis]].<ref>Sanofi Pasteur MSD [http://www.spmsd.co.uk/cat.asp?catid=394 Annual Report and Accounts 2006]</ref>

	== Corporate social responsibility at Merck ==		== Corporate social responsibility at Merck ==

@@ Line 62: / Line 62: @@
 Merck appears as a client with [[Rabin Strategic Partners]]<ref>Rabin Strategic Partners [http://www.rabinpartners.com/ Our Clients] Accessed 2nd January 2008</ref> (A full-service consultany, public relations and communications agency) alongside [[Johnson & Johnson]]. However the nature of the link between the two companies is not divulged.
-Merck & Co is listed as a client of business intelligence firm [[Business Insights]]<ref> Business Insights [http://globalbusinessinsights.com/content/rbhc0019m.pdf Patient Power: The shift towards more informed, more powerful consumers of drugs] Accessed 5th February 2008</ref>
+Merck & Co is listed as a client of business intelligence firm [[Business Insights]]<ref> Business Insights [http://globalbusinessinsights.com/content/rbhc0019m.pdf Patient Power: The shift towards more informed, more powerful consumers of drugs] Accessed 5th February 2008</ref> and The [[Gorlin Group]]<ref>The Gorlin Group [http://www.gorlingroup.com/ Clients] Accessed 20th March 2008</ref>
 E Merck and Merck Sharp and Dohme are listed as clients of [[Innovex]]<ref> Innovex [http://www.innovexcareers.com/content_static/c_ourcustomers.asp?session_id={212F403D-EE9F-433B-A03A-E66AB35FB45E} Our Customers] Accessed 12th February 2008</ref>